Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Practical Neurology|September 12, 2025
Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update)Saiju Jacob, Maria Elena Farrugia, Channa Hewamadduma, et al.
Archives of Neurology|July 16, 2008
Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitisPatrick Waters, Sven Jarius, Edward Littleton, et al.
Neuromuscular Disorders : NMD|February 12, 2009
Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in twoBenedikt Schoser, Saiju Jacob, David Hilton-Jones, et al.
Annals of the New York Academy of Sciences|June 24, 2008
Myasthenia gravis seronegative for acetylcholine receptor antibodiesAngela Vincent, Maria Isabel Leite, Maria Elena Farrugia, et al.
Advances in Therapy|March 12, 2026
Indirect Comparison of Nipocalimab Versus Efgartigimod and Rozanolixizumab in the Treatment of Generalized Myasthenia GravisSaiju Jacob, Mahmoud Hashim, Brian Hutton, et al.
Practical Neurology|November 12, 2024
Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidanceWaqar Rashid, Olga Ciccarelli, Siobhan M Leary, et al.
Journal of Neuropathology and Experimental Neurology|December 13, 2016
Tubular Aggregates and Cylindrical Spirals Have Distinct Immunohistochemical SignaturesStefen Brady, Estelle G Healy, Qiang Gang, et al.
Insights Into Imaging|July 19, 2020
Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesionsVijay Sawlani, Markand Dipankumar Patel, Nigel Davies, et al.
Annals of Clinical and Translational Neurology|May 16, 2018
Seronegative antibody-mediated neurology after immune checkpoint inhibitorsRobert Wilson, David A Menassa, Alexander J Davies, et al.
Pageof 7